Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Abstracto

NMOSD Management in the Setting of Chronic Hepatitis B and Latent Tuberculosis: A Case Report

Dylan Sadowsky BS, Kevin Delijani BS, William Davis MD, Amy Safadi MD, Petra Brayo MD, Benjamin Osborne MD

Neuromyelitis Optica Spectrum Disorder (NMOSD) is an inflammatory autoimmune disorder of the central nervous system, with optic neuritis and transverse myelitis as its most common presentations. Although immunomodulatory treatment options for NMOSD have expanded, preventing reactivation of latent infections in patients can still be a therapeutic challenge. Our patient presented to the emergency department during an NMOSD pseudo-relapse with untreated latent tuberculosis (TB) and chronic hepatitis B and was briefly treated with high-dose IV methylprednisolone. After confirmation that neither hepatitis B nor TB had reactivated, the patient was discharged on isoniazid and entecavir. A month later she was started on inebilizumab for relapse prevention of NMOSD. This case report highlights the therapeutic complexities of managing NMOSD that requires immunosuppression in the setting of preventing reactivation of TB and hepatitis B.

Descargo de responsabilidad: este resumen se tradujo utilizando herramientas de inteligencia artificial y aún no ha sido revisado ni verificado.